Sfoglia per AUTORE
HERMINE O
Collezione AOU Città della Salute di Torino

  

Items : 7

Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression). in Leukemia / Leukemia. 2023 Sep;37(9):1887-1894. doi: 10.1038/s41375-023-01977-y. Epub 2023 Jul 26.
2023
AOU Alessandria
AOU Città della Salute di Torino

Hoster E; Jerkeman M; Ferrero S; Ladetto M; Klapper W; Evangelista A; Unterhalt M; Rosenwald A; Kluin-Nelemans HC; Schmidt C; Jiang L; Hermine O; Dreyling M; Scheubeck G;

Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry. in HemaSphere / Hemasphere. 2022 Apr 8;6(5):e0711. doi: 10.1097/HS9.0000000000000711. eCollection 2022 May.
2022
AOU Città della Salute di Torino

Tilch MK; Visco C; Kinda S; Hermine O; Kohn M; Besson C; Lamure S; Duléry R; Ragaini S; Eyre TA; Van Meerten T; Ohler A; Eckerle S; Dreyling M; Hess G; Giné E; Gomes da Silva M;

Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma. in The New England journal of medicine / N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3.
2022
AOU Città della Salute di Torino

Wang ML; Jurczak W; Jerkeman M; Trotman J; Zinzani PL; Belada D; Boccomini C; Flinn IW; Giri P; Goy A; Hamlin PA; Hermine O; Hernández-Rivas JÁ; Hong X; Kim SJ; Lewis D; Mishima Y; Özcan M; Perini GF; Pocock C; Song Y; Spurgeon SE; Storring JM; Walewski J; Zhu J; Qin R; Henninger T; Deshpande S; Howes A; et alii...

A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):188. doi: 10.3390/cancers14010188.
2021
AOU Alessandria
AOU Città della Salute di Torino

Hermine O; Vitolo U; Guarini A; Fabbri A; Patti C; Latte G; Spina M; Pascarella A; Vallisa D; Merli F; Di Renzo N; Cabras MG; Moia R; Volpetti S; Tani M; Del Giudice I; Barbero D; Ghislieri M; Drandi D; Genuardi E; Evangelista A; Passera R; Hoster E; Ferrero S; Zaccaria GM; Kluin-Nelemans HC; Cortelazzo S; Dreyling M; Ladetto M; et alii...

Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network. in HemaSphere / Hemasphere. 2020 Apr 3;4(2):e347. doi: 10.1097/HS9.0000000000000347. eCollection 2020 Apr.
2020
AOU Alessandria
AOU Città della Salute di Torino

Hermine O; Dreyling M; Cortelazzo S; Ribrag V; Eckert C; Abdo C; Callanan M; Jimenez C; Ciabatti E; Bomben R; Starza ID; Cheminant M; Villarese P; Mantoan B; Genuardi E; Ferrante M; Zaccaria G; Lhermitte L; Söhlbrandt A; Benmaad I; Alcantara M; Drandi D; Delfau-Larue MH; Pott C; Ladetto M; Ferrero S; Macintyre E;

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death. in British journal of haematology / Br J Haematol. 2019 Jun;185(5):940-944. doi: 10.1111/bjh.15643. Epub 2018 Nov 8.
2019
AOU Città della Salute di Torino
AOU Novara

Vitolo U; Hoster E; Martelli M; Ruggeri M; Dreyling M; Hermine O; Loseto G; Pelosini M; Gentile M; Piazza F; Merli M; Marino D; Arcari A; Puccini B; Alvarez De Celis I; Ferrero S; Cox MC; Finolezzi E; Fabbri A; Molinari AL; Perrone T; Nassi L; Gini G; Morello L; Chiappella A; Tecchio C; Re A; Sciarra R; Hohaus S; et alii...

The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma. in Leukemia / Leukemia. 2015 Feb;29(2):464-73. doi: 10.1038/leu.2014.223. Epub 2014 Jul 18.
2015
AOU Città della Salute di Torino

Vitolo U; Rule S; Kimby E; Le Gouill S; Ghielmini M; Geisler C; Caballero D; Corradini P; Dreger P; Robinson S; Dreyling M; Hermine O;